Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCG vaccine--current status.

V Vijayalakshmi1, K J Murthy

  • 1Mahavir Hospital & Research Centre, Hyderabad.

Journal of the Indian Medical Association
|October 4, 2000
PubMed
Summary

Tuberculosis is re-emerging, and the Bacillus Calmette-Guérin (BCG) vaccine needs improvement. Research suggests a second dose may boost waning immunity against tuberculosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do traditional masculine norms predict emotion regulation? A cross-cultural quantitative study of urban Indian men.

Frontiers in sociology·2026
Same author

Agility and the three musketeers: The interplay of epistemic curiosity, joy, and rumination.

Acta psychologica·2025
Same author

Arts as a driver of agility: A mixed-method inquiry.

Acta psychologica·2024
Same author

Creating a resilient pedagogy: Character strengths intervention for aspiring educators.

Acta psychologica·2024
Same author

Author Correction: Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India.

Scientific reports·2024
Same author

Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India.

Scientific reports·2024

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Tuberculosis (TB) incidence is rising globally, driven by multidrug resistance and HIV co-infection.
  • The Bacillus Calmette-Guérin (BCG) vaccine is the primary vaccine used globally for tuberculosis prevention in children.
  • BCG vaccination primarily protects against severe, disseminated forms of childhood tuberculosis.

Purpose of the Study:

  • To address the need for improved tuberculosis vaccines.
  • To explore strategies for enhancing the efficacy of existing tuberculosis vaccines.
  • To investigate the potential benefits of a second dose of BCG vaccine to overcome waning immunity.

Main Methods:

  • Review of existing literature on BCG vaccine efficacy and duration of protection.
  • Analysis of studies investigating the impact of revaccination or booster doses.
  • Evaluation of immune responses elicited by BCG vaccination.

Main Results:

  • The protective effect of the BCG vaccine wanes over time, necessitating potential booster strategies.
  • Several studies suggest that a second dose of BCG may enhance protection against tuberculosis.
  • Ideal vaccines should elicit robust and long-lasting protective immune responses.

Conclusions:

  • The current BCG vaccine requires enhancement to improve its long-term efficacy against tuberculosis.
  • Further research into booster vaccination strategies, such as a second BCG dose, is warranted.
  • Developing vaccines that induce strong protective immune responses is crucial for effective tuberculosis control.

Related Experiment Videos